Abstract
Homeostasis of most tissues and organs is maintained by tissue-specific somatic or adult stem cells (SCs) and their early progenitors possessing two main properties: self-renewal and differentiation. To fulfil these two functions, they must undergo either symmetrical division for stem cell expansion, necessary after injury for example, or asymmetrical division for stem cell maintenance and progenitor production. The “cancer stem cell hypothesis” postulates that tumours arise from adult stem cells called cancer stem cells (CSCs) that possess stem cell properties. There is growing evidence that most solid tumours and haematological malignancies are driven by CSCs as a result of advances in stem cell biology and the development of animal models. This has fundamental implications for understanding the biology of cancers and also for developing new therapeutic strategies. The recent characterisation of CSC in head and neck squamous cell carcinoma (HNSCC) prompted us to re-examine the disease development and to discuss the limited effects of conventional therapies.
Keywords: Stem cell, cancer stem cell, p63, head and neck squamous cell carcinoma, oral epithelium
Current Cancer Therapy Reviews
Title: Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
Volume: 5 Issue: 2
Author(s): Mathilde Lechevrel and Brigitte Sola
Affiliation:
Keywords: Stem cell, cancer stem cell, p63, head and neck squamous cell carcinoma, oral epithelium
Abstract: Homeostasis of most tissues and organs is maintained by tissue-specific somatic or adult stem cells (SCs) and their early progenitors possessing two main properties: self-renewal and differentiation. To fulfil these two functions, they must undergo either symmetrical division for stem cell expansion, necessary after injury for example, or asymmetrical division for stem cell maintenance and progenitor production. The “cancer stem cell hypothesis” postulates that tumours arise from adult stem cells called cancer stem cells (CSCs) that possess stem cell properties. There is growing evidence that most solid tumours and haematological malignancies are driven by CSCs as a result of advances in stem cell biology and the development of animal models. This has fundamental implications for understanding the biology of cancers and also for developing new therapeutic strategies. The recent characterisation of CSC in head and neck squamous cell carcinoma (HNSCC) prompted us to re-examine the disease development and to discuss the limited effects of conventional therapies.
Export Options
About this article
Cite this article as:
Lechevrel Mathilde and Sola Brigitte, Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma, Current Cancer Therapy Reviews 2009; 5 (2) . https://dx.doi.org/10.2174/157339409788166797
DOI https://dx.doi.org/10.2174/157339409788166797 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment
Current Pharmaceutical Design A High-throughput Quantitative Expression Analysis of Cancer-related Genes in Human HepG2 Cells in Response to Limonene, a Potential Anticancer Agent
Current Cancer Drug Targets Mitochondria in Cancer Stem Cells: A Target for Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) When Ubiquitin Meets NF-κB: A Trove for Anti-cancer Drug Development
Current Pharmaceutical Design Review of MiRNA-Disease Association Prediction
Current Protein & Peptide Science Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery
Recent Patents on Anti-Cancer Drug Discovery Targetting Esophageal and Gastric Cancers with Monoclonal Antibodies
Current Topics in Medicinal Chemistry Mn-SOD and Chronic Inflammation of Gastric Mucosa
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors
Current Topics in Medicinal Chemistry Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Viruses and Oral Cancer: Crossreactivity as a Potential Link
Anti-Cancer Agents in Medicinal Chemistry miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance
Current Gene Therapy Sunlight Vitamin D and Skin Cancer
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs in Non-small Cell Lung Cancer: Current Status and Future Therapeutic Promises
Current Pharmaceutical Design Histone Deacetylase Inhibitors and Colorectal Cancer: what is new?
Anti-Cancer Agents in Medicinal Chemistry Strategies for Overcoming Inherent and Acquired Resistance to EGFR Inhibitors by Targeting Downstream Effectors in the RAS/PI3K Pathway
Current Cancer Drug Targets Phospho-eIF4E: A New Target for Acute Myeloid Leukemia
Current Protein & Peptide Science “Metabolic Reprogramming” in Ovarian Cancer Cells Resistant to Cisplatin
Current Cancer Drug Targets Inhibitors of the Ubiquitin-Proteasome System and the Cell Death Machinery: How Many Pathways are Activated?
Current Molecular Pharmacology microRNAs in Cancer: Lessons from Melanoma
Current Pharmaceutical Design